je.st
news
Lab21 And IntegraGen Partner To Develop New Colorectal Cancer Diagnostic
2013-02-22 06:09:00| drugdiscoveryonline Home Page
Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes
Tags: partner
develop
cancer
diagnostic
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||